These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24504843)

  • 1. Role of external beam radiotherapy in the treatment of relapsing meningioma.
    Buglione M; De Bari B; Trevisan F; Ghirardelli P; Pedretti S; Triggiani L; Magrini SM
    Med Oncol; 2014 Mar; 31(3):866. PubMed ID: 24504843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
    Detti B; Scoccianti S; Di Cataldo V; Monteleone E; Cipressi S; Bordi L; Pellicanò G; Gadda D; Saieva C; Greto D; Pecchioli G; Buccoliero A; Ceroti M; Ammannati F; Biti G
    J Neurooncol; 2013 Dec; 115(3):421-7. PubMed ID: 24045968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
    Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
    Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
    Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
    Aizer AA; Arvold ND; Catalano P; Claus EB; Golby AJ; Johnson MD; Al-Mefty O; Wen PY; Reardon DA; Lee EQ; Nayak L; Rinne ML; Beroukhim R; Weiss SE; Ramkissoon SH; Abedalthagafi M; Santagata S; Dunn IF; Alexander BM
    Neuro Oncol; 2014 Nov; 16(11):1547-53. PubMed ID: 24891451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
    Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
    J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
    Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
    J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors.
    Desideri I; Morelli I; Banini M; Greto D; Visani L; Nozzoli F; Caini S; Della Puppa A; Livi L; Perini Z; Zivelonghi E; Bulgarelli G; Pinzi V; Navarria P; Clerici E; Scorsetti M; Ascolese AM; Osti MF; Anselmo P; Amelio D; Minniti G; Scartoni D
    Radiother Oncol; 2024 Jun; 195():110271. PubMed ID: 38588920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation with proton radiation therapy for high-grade meningiomas.
    Chan AW; Bernstein KD; Adams JA; Parambi RJ; Loeffler JS
    Technol Cancer Res Treat; 2012 Dec; 11(6):607-14. PubMed ID: 22712601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
    Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of conventional radiotherapy for recurrent meningioma.
    Kokubo M; Shibamoto Y; Takahashi JA; Sasai K; Oya N; Hashimoto N; Hiraoka M
    J Neurooncol; 2000 May; 48(1):51-5. PubMed ID: 11026697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
    Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
    J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
    Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
    Strahlenther Onkol; 2006 Nov; 182(11):635-40. PubMed ID: 17072520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-Guided Robotic Radiosurgery for Treatment of Recurrent Grade II and III Meningiomas. A Single-Center Study.
    Acker G; Meinert F; Conti A; Kufeld M; Jelgersma C; Nguyen P; Kluge A; Lukas M; Loebel F; Pasemann D; Kaul D; Budach V; Vajkoczy P; Senger C
    World Neurosurg; 2019 Nov; 131():e96-e107. PubMed ID: 31306844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.